The Pharmaceutical Distribution segment is a core part of Suzuken's operations, focusing on the procurement and distribution of ethical drugs, diagnostic reagents, medical equipment, and supplies. This segment utilizes advanced logistics and supply chain management to ensure timely and efficient delivery to medical institutions and pharmacies across Japan and internationally. The segment's activities include managing a vast network of suppliers and customers, implementing smart logistics solutions, and leveraging data analytics to optimize distribution processes. This segment plays a crucial role in ensuring access to essential medicines and medical supplies, impacting patient care and outcomes by supporting healthcare providers with the resources they need. Future opportunities include expanding distribution networks, integrating digital health solutions, and enhancing supply chain resilience. The segment collaborates with various pharmaceutical manufacturers and healthcare providers to improve healthcare delivery.

The Pharmaceutical Manufacturing segment is dedicated to the research, development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products. This segment focuses on therapeutic areas such as diabetes and kidney diseases, aiming to develop innovative treatments and diagnostic tools. Research and development activities include drug discovery, preclinical studies, and clinical trials. The segment utilizes advanced technologies and methodologies in drug formulation, manufacturing processes, and quality control. The patient impact is significant, as the segment's products address critical health needs and improve patient outcomes. Market positioning is enhanced through strategic partnerships and collaborations with research institutions and other pharmaceutical companies. Future opportunities include expanding the product pipeline, entering new therapeutic areas, and leveraging advanced manufacturing technologies. Regulatory and clinical aspects are managed to ensure compliance with all relevant guidelines and standards.

The Pharmacy Business segment provides services through family pharmacists, improving the operations of local pharmacies and providing educational support. This segment focuses on enhancing patient care and medication management through community-based pharmacy services. The segment leverages technology to improve pharmacy operations, including dispensing systems, patient record management, and medication adherence programs. The therapeutic areas covered include a wide range of conditions, with a focus on chronic disease management and preventative care. The patient impact is significant, as the segment provides accessible and personalized healthcare services, improving medication adherence and patient outcomes. Market positioning is strengthened through partnerships with healthcare providers and community organizations. Future opportunities include expanding pharmacy networks, integrating digital health solutions, and offering specialized pharmacy services. Regulatory and clinical aspects are managed to ensure compliance with all relevant guidelines and standards.

The Healthcare-Related Services segment offers a range of services, including manufacturer support services (contract distribution for manufacturers, distribution of orphan drugs), nursing care services, and the development, manufacturing, and sale of medical devices such as electrocardiographs, sphygmomanometers, and stethoscopes. This segment leverages advanced technologies in medical device development and manufacturing, focusing on improving diagnostic accuracy and patient monitoring. The therapeutic areas covered include cardiology, general practice, and home healthcare. The patient impact is significant, as the segment's products and services improve diagnostic capabilities, facilitate remote patient monitoring, and support the delivery of quality healthcare. Market positioning is enhanced through strategic partnerships with medical device manufacturers and healthcare providers. Future opportunities include expanding the product portfolio, entering new markets, and integrating digital health solutions. Regulatory and clinical aspects are managed to ensure compliance with all relevant guidelines and standards.